Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 15.45% on an annualized basis producing an average annual return of 22.72%. Currently, Regeneron Pharmaceuticals has a market capitalization of $87.68 billion.
Buying $100 In REGN: If an investor had bought $100 of REGN stock 20 years ago, it would be worth $6,000.82 today based on a price of $807.69 for REGN at the time of writing.
Regeneron Pharmaceuticals’s Performance Over Last 20 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
